Edward J Dulac III

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Mar 25	NTLA Intellia Therapeutics	Common Stock	Grant	Acquire A	No	No	0	47,200	0.00	113,524
1 Mar 25	NTLA Intellia Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	10.09	67,429	680.36 k	67,429
22 Jul 24	NTLA Intellia Therapeutics	Common Stock	Grant	Acquire A	No	No	0	66,324	0.00	66,324
22 Jul 24	NTLA Intellia Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	25.33	96,219	2.44 mm	96,219
4 Mar 24	FATE Fate Therapeutics	Common Stock	Sell	Dispose S	No	Yes	7.77	2,447	19.01 k	101,479
1 Feb 24	FATE Fate Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	6.76	425,000	2.87 mm	425,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.